Puneet Souda
Stock Analyst at Leerink Partners
(1.55)
# 3,408
Out of 4,983 analysts
215
Total ratings
47.43%
Success rate
-1.35%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Upgrades: Outperform | $16 | $8.99 | +77.98% | 7 | Aug 6, 2025 | |
| MASS 908 Devices | Upgrades: Outperform | $12 | $6.16 | +94.81% | 7 | Aug 5, 2025 | |
| QTRX Quanterix | Downgrades: Market Perform | $12 → $8 | $5.28 | +51.52% | 12 | Apr 30, 2025 | |
| NEO NeoGenomics | Downgrades: Market Perform | $25 → $9 | $7.99 | +12.64% | 10 | Apr 30, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | $80 → $75 | $63.33 | +18.43% | 7 | Feb 6, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $7.50 | +180.00% | 7 | Dec 9, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $32.28 | +23.92% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $175.01 | -14.29% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $303.08 | +23.73% | 15 | Aug 1, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $630 | $480.74 | +31.05% | 19 | Jul 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $35 | $21.75 | +60.92% | 11 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $145 | $127.19 | +14.00% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $190.47 | +57.51% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $101.48 | +146.35% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $51.78 | +112.44% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $52.94 | +41.67% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $119.75 | +67.01% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $4.77 | +277.36% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $1.61 | +272.67% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $27.08 | +10.78% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $33.26 | +161.58% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $55.40 | +152.71% | 5 | Feb 24, 2022 |
Cryoport
Aug 6, 2025
Upgrades: Outperform
Price Target: $16
Current: $8.99
Upside: +77.98%
908 Devices
Aug 5, 2025
Upgrades: Outperform
Price Target: $12
Current: $6.16
Upside: +94.81%
Quanterix
Apr 30, 2025
Downgrades: Market Perform
Price Target: $12 → $8
Current: $5.28
Upside: +51.52%
NeoGenomics
Apr 30, 2025
Downgrades: Market Perform
Price Target: $25 → $9
Current: $7.99
Upside: +12.64%
Hologic
Feb 6, 2025
Downgrades: Market Perform
Price Target: $80 → $75
Current: $63.33
Upside: +18.43%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $7.50
Upside: +180.00%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $32.28
Upside: +23.92%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $175.01
Upside: -14.29%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $303.08
Upside: +23.73%
Thermo Fisher Scientific
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $480.74
Upside: +31.05%
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $21.75
Upside: +60.92%
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $127.19
Upside: +14.00%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $190.47
Upside: +57.51%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $101.48
Upside: +146.35%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $51.78
Upside: +112.44%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $52.94
Upside: +41.67%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $119.75
Upside: +67.01%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $4.77
Upside: +277.36%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $1.61
Upside: +272.67%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $27.08
Upside: +10.78%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $33.26
Upside: +161.58%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $55.40
Upside: +152.71%